Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by palinc2000on Dec 20, 2021 10:13am
78 Views
Post# 34246588

RE:Anyone think the ATM has already been accessed?

RE:Anyone think the ATM has already been accessed?The recent fikings still showed 50 million $  renewal which I thought meant that there had been no sales under the ATM  ,Maybe this is a wrong interpretation and I really dont feel like spending a lot of time on a thorouigh reading of the Filings,

We know that there is a substantial need for money,It is often said that Necessity is the Mother of Invention,,There was zero invention when they did the OO,,,Lets hope that the next raise shows some innovative terms but our CFO has not shown any of the skills required to achieve that.

SPCEO1 wrote: When you think back to the time when the stock price stayed at $3.50 for the better part of a month, it is possible what was going on then was THTX and an institution had agreed on a price around that level for the institution to buy stock from the ATM. There was nothing in the recent filings that said that but thinking back on it, it is certainly a possibility as that trading was really strange and something has to account for it. We will likely not know until TH files its next quarterly report in February. And they could easily sell more between now and then. 

Also, in case you did not read through my Weekly Report Card, I noted there that Egrifta sales fell about 6-7% quarter-over-quarter in 4Q21 and probably rose about 2% year-over-year based on Bloomberg's sales estimator which does not have a reputation for accuracy and slight adjustments I made for price increases in the year-over-year number. For Trogarzo, sales were up around 14% quarter-over-quarter and around 27% year-over-year. I am not sure if international sales are captured by Bloomberg but with those big numbers for Trogarzo, it looks like that might be the case. 


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse